Antiangiogenic mechanisms of simvastatin in retinal endothelial cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Graefe's Archive for Clinical and Experimental Ophthalmology

• Publication date

  2010-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00417-009-1282-4PMID 20155363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins

  2008cited by this paper
• The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies

  2008cited by this paper
• Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor

  2008cited by this paper
• Anti-vascular endothelial growth factor therapy for ocular neovascular disease

  2007cited by this paper
• Mevalonate pathway: a review of clinical and therapeutical implications.

  2007cited by this paper
• Intracellular events in retinal glial cells exposed to ICG and BBG.

  2007cited by this paper
• Breast cancer growth prevention by statins.

  2006cited by this paper
• Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis

  2006cited by this paper
• Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.

  2004cited by this paper
• Functional properties of hyalocytes under PDGF-rich conditions.

  2004cited by this paper
• Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Hydroxymethylglutaryl-Coenzyme A Reductase Inhibitors in Osteoporosis Management

  2002cited by this paper
• Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models

  2002cited by this paper
• 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoA

  2002influential reference
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Statins Have Biphasic Effects on Angiogenesis

  2002cited by this paper
• ERRATA

  2001cited by this paper
• Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.

  2000cited by this paper
• The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

  2000cited by this paper
• Angiogenesis and Its Regulation: Roles of Vascular Endothelial Cell Growth Factor

  2000cited by this paper
• A Role for P21-Activated Kinase in Endothelial Cell Migration

  1999cited by this paper
• Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

  1999cited by this paper
• Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

  1998cited by this paper
• Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis

  1995cited by this paper
• Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.

  1988cited by this paper

• The effect of simvastatin treatment on TNF-alpha-induced inflammation in human vascular endothelial cells (HUVECs)

  2023cites this paper
• Statins and angiogenesis in non-cardiovascular diseases.

  2022cites this paper
• Intensive treat-to-target statin therapy and severity of diabetic retinopathy complicated by hypercholesterolaemia

  2020cites this paper
• Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy.

  2020cites this paper
• Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy

  2020cites this paper
• Role of lipid-lowering agents in the management of diabetic retinopathy

  2017cites this paper
• In vitro and ex vivo retina angiogenesis assays

  2014cites this paper
• Simvastatin Radiosensitizes Differentiated and Stem‐Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation

  2014cites this paper
• Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.

  2013cites this paper
• The effects of different types of statins on proliferation and migration of HGF-induced Human Umbilical Vein Endothelial Cells (HUVECs).

  2013cites this paper
• Effects of Simvastatin on the Expression of VEGF in Human Retinal Pigment Epithelial Cells

  2012cites this paper
• Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.

  2012cites this paper
• Transgelin 2 Participates in Lovastatin-Induced Anti-Angiogenic Effects in Endothelial Cells through a Phosphorylated Myosin Light Chain-Related Mechanism

  2012cites this paper
• Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

  2011cites this paper
• Induction of Angiogenesis and Modulation of Vascular Endothelial Growth Factor Receptor-2 by Simvastatin After Traumatic Brain Injury

  2011cites this paper